OPTN News and Press, OptiNose Inc. From 03/03/21

Ovid Therapeutics (OVID) +73% after soticlestat deal with Takeda.KemPharm (KMPH) +69% on FDA approval of ADHD drug.Ocugen, Inc. (OCGN) +39% on Indian partner’s COVID-19 vaccine efficacy data.Asensus Surgical (TRXC) +33% on FDA clearance for Senhance Surgical System....

OptiNose (OPTN): Q4 GAAP EPS of -$0.46 misses by $0.01.Revenue of $16.4M (+48.0% Y/Y) misses by $1.58M.Shares -0.77% PM.Press Release For further details see: OptiNose EPS misses by $0.01, misses on revenue

Company reports fourth quarter and full year 2020 XHANCE net revenue of $15.6 million and $48.4 million Full year 2020 XHANCE prescriptions increased 70% compared to full year 2019 Company expects XHANCE net revenue for 2021 to be at least $80 million Company exp...

Gainers: [[SIOX]] +12.1%. [[OPTN]] +7.2%. [[BDSI]] +5.7%. [[SSP]] +4.9%. [[SPPI]] +4.9%.Losers: [[PCTI]] -6.5%. [[SVC]] -5.4%. [[GNFT]] -4.2%. [[NIU]] -3.4% [[CATB]] -2%. For further details see: NIU, SPPI, BDSI and SVC among after-hours movers

Conference Call and Webcast to be held March 3, 2021 at 8:00 a.m. Eastern Time Company to Present at the Cowen 41 st Annual Health Care Conference on March 4, 2021 YARDLEY, Pa., Feb. 17, 2021 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical comp...

YARDLEY, Pa., Dec. 21, 2020 (GLOBE NEWSWIRE) -- Opti N ose , Inc. (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced that the company has granted non-qualified stock option awards to purchase...

After COVID-19 slowed their commercial launch, OPTN is doing an exceptional job selling Xhance. Q3 2020 revenues grew ~50% from Q2 & consensus FY2021 revenue estimates forecast 100% growth. Professional analysts forecast $700MM in peak Xhance sales (some forecast peak sales in the...

Gainers: DPW Holdings (DPW) +179%.Ideanomics (IDEX) +65%.Fuel Tech (FTEK) +61%.Greenland Technologies (GTEC) +52%.Kaixin Auto (KXIN) +52%.FuelCell Energy (FCEL) +45%.CIIG Merger (CIIC) +37%.Graybug Vision (GRAY) +36%.Beam Global (BEEM) +35%.Marathon Patent (MARA) +33%.Losers: B...

Gainers: Medigus (MDGS) +36%, 180 Life Sciences (ATNF) +35%, Graybug Vision (GRAY) +23%, Trinity Biotech (TRIB) +18%, Accuray (ARAY) +14%.Losers: Bellerophon Therapeutics (BLPH) -18%, BioLineRx (BLRX) -13%, AIM ImmunoTech (AIM) -11%, iBio...

OptiNose, Inc. (OPTN) Q3 2020 Results Conference Call November 05, 2020 08:00 AM ET Company Participants Jonathan Neely - Vice President, Investor Relations Peter Miller - Chief Executive Officer Ramy Mahmoud - President and Chief Operating Officer Vic Clavelli - Chief Commercial Officer Keit...